0J9P.L
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO for the treatment of chronic graft-versus-host disease. It also provides INCA033989 for the treatment of essential thrombocythemia and MF; INCA035784 fo...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0J9P.L
According to Incyte Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 15.71. This represents a change of 26.59% compared to the average of 12.41 of the last 4 quarters.
The mean historical PE Ratio of Incyte Corporation over the last ten years is 76.05. The current 15.71 PE Ratio has changed 1.97% with respect to the historical average. Over the past ten years (40 quarters), 0J9P.L's PE Ratio was at its highest in in the December 2016 quarter at 501.35. The PE Ratio was at its lowest in in the June 2017 quarter at -516.87.
Average
76.05
Median
32.75
Minimum
-63.96
Maximum
431.69
Discovering the peaks and valleys of Incyte Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.74%
Maximum Annual PE Ratio = 431.69
Minimum Annual Increase = -297.55%
Minimum Annual PE Ratio = -63.96
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 14.99 | -96.53% |
| 2024 | 431.69 | 1.74% |
| 2023 | 23.52 | -55.20% |
| 2022 | 52.50 | 207.54% |
| 2021 | 17.07 | -126.69% |
| 2020 | -63.96 | -252.35% |
| 2019 | 41.98 | -65.67% |
| 2018 | 122.29 | -297.55% |
| 2017 | -61.90 | -133.95% |
| 2016 | 182.31 | -93.28% |
The current PE Ratio of Incyte Corporation (0J9P.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
156.73
5-year avg
107.95
10-year avg
76.05
Incyte Corporation’s PE Ratio is less than Waters Corporation (47.99), less than Illumina, Inc. (34.34), less than Quest Diagnostics Incorporated (22.84), less than Biogen Inc. (22.30), less than Labcorp Holdings Inc. (24.80), greater than Centene Corporation (-4.87), less than Hologic, Inc. (31.28), less than Neurocrine Biosciences, Inc. (25.57), less than Exelixis, Inc. (17.85), less than Mettler-Toledo International Inc. (31.24),
| Company | PE Ratio | Market cap |
|---|---|---|
| 47.99 | N/A | |
| 34.34 | N/A | |
| 22.84 | N/A | |
| 22.30 | N/A | |
| 24.80 | N/A | |
| -4.87 | N/A | |
| 31.28 | N/A | |
| 25.57 | N/A | |
| 17.85 | N/A | |
| 31.24 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Incyte Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Incyte Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Incyte Corporation's PE Ratio?
How is the PE Ratio calculated for Incyte Corporation (0J9P.L)?
What is the highest PE Ratio for Incyte Corporation (0J9P.L)?
What is the 3-year average PE Ratio for Incyte Corporation (0J9P.L)?
What is the 5-year average PE Ratio for Incyte Corporation (0J9P.L)?
How does the current PE Ratio for Incyte Corporation (0J9P.L) compare to its historical average?